发明名称 |
Medicinal compositions for angiogenic therapy |
摘要 |
<p>The present invention provides: (1) pharmaceutical compositions for angiogenic therapy which contain, as the active ingredients, at least one substance selected from substances having vasodilating effect and/or platelet aggregation inhibitory effect, and substances producing them; and a gene encoding an angiogenesis factor; (2) agents for potentiating the angiogenic effect of a gene encoding an angiogenesis factor that contain, as the active ingredient, at least one substance selected from substances having vasodilating effect and/or platelet aggregation inhibitory effect and substances producing them; (3) an angiogenic agent which contains a prostacyclin synthase gene as the active ingredient; (4) pharmaceutical compositions for angiogenic therapy which contain ets-1 gene and another gene encoding an angiogenesis factor as the active ingredients; (4) an agent which contain ets-1 gene as the active ingredient for potentiating the angiogenic effect of another gene encoding an angiogenesis factor; and (5) an angiogenic agent which contains ets-1 gene as the active ingredient.</p> |
申请公布号 |
EP1889633(A1) |
申请公布日期 |
2008.02.20 |
申请号 |
EP20070021738 |
申请日期 |
2001.06.27 |
申请人 |
ANGES MG, INC.;MORISHITA, RYUICHI |
发明人 |
MORISHITA, RYUICHI;KOIKE, HIROMI;TANABE, TADASHI;AOKI, MOTOKUNI |
分类号 |
A61K45/00;A61K31/5585;A61K31/711;A61K38/16;A61K38/17;A61K38/18;A61K38/52;A61K48/00;A61P9/00;A61P9/10 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|